Charnwood Molecular and Aurelia Bioscience, both with labs at BioCity Nottingham, have expanded their alliance aimed at enabling more efficient global delivery of discovery projects to pharma/biopharma clients.   Aurelia Bioscience specializes in the development of bioassays and the screening of compounds for initial hit identification at medium/high throughput and on-going compound refinement in the hit/lead stages of medicinal chemistry programs.   Compounds for the various stages of these...